BDBM235949 US9365534, HU-974
SMILES: CCCCCc1cc(OC)c(C2=C[C@H]3CC[C@]2(C(O)=O)C3(C)C)c(OC)c1
InChI Key: InChIKey=WCZNJFCRMLMUIK-MWTRTKDXSA-N
Data: 1 KI
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Cannabinoid receptor 2 (Homo sapiens (Human)) | BDBM235949 (US9365534, HU-974) | PDB Reactome pathway KEGG UniProtKB/SwissProt UniProtKB/TrEMBL DrugBank antibodypedia GoogleScholar AffyNet | PC cid PC sid UniChem | US Patent | >1.00E+4 | >-6.93 | n/a | n/a | n/a | n/a | n/a | 7.4 | 30 |
YISSUM RESEARCH DEVELOPMENT COMPANY OF THE HEBREW UNIVERSITY OF JERUSALEM LTD. US Patent | Assay Description The Kd of CP 55,940 in the isolated CB1 and CB2 receptor expressing membranes was previously determined to be 2.3 nM and 1.5 nM, respectively (see Pe... | US Patent US9365534 (2016) BindingDB Entry DOI: 10.7270/Q2639NN9 | |||||||||||
More data for this Ligand-Target Pair |